Status:
COMPLETED
Evaluation of OxxyneaGS in Acute Glycemic Regulation on Light Hyperglycemic Subjects
Lead Sponsor:
Fytexia
Conditions:
Hyperglycemia, Postprandial
Eligibility:
All Genders
20-50 years
Phase:
NA
Brief Summary
This study aims to evaluate and select the best combination of polyphenol and white kidney bean ingredients in the acute glycemic modulation after a complete meal by measuring blood glucose and insuli...
Eligibility Criteria
Inclusion
- Glycemia: 100-125mg/dL
- Both sexes
- Overweight BMI range (27-32)
- Age: 20-50 years old
Exclusion
- Metabolic/Chronical disease
- Menopausal women
- Being pregnant, breastfeeding or wanting to have a baby
- Former obese with a history of yoyo effect
- Have been involved in a weight loss program in the past 12 months or subjected to weight reduction surgery
- Having started or quit smoking, having a high alcohol consumption
- Have in the past been in a long-term antibiotherapy (1 month or more) and/or a regular antibiotherapy in the past 12 months
- Allergy to olive, artichoke, black currant, grapefruit, grape, white kidney bean, olive, pomegranate.
Key Trial Info
Start Date :
June 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04914416
Start Date
June 15 2021
End Date
May 30 2022
Last Update
August 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCAM
Murcia, Spain, 30107